1. Home
  2. KPTI vs GDO Comparison

KPTI vs GDO Comparison

Compare KPTI & GDO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Karyopharm Therapeutics Inc.

KPTI

Karyopharm Therapeutics Inc.

HOLD

Current Price

$5.77

Market Cap

172.6M

Sector

Health Care

ML Signal

HOLD

Logo Western Asset Global Corporate Defined Opportunity Fund Inc.

GDO

Western Asset Global Corporate Defined Opportunity Fund Inc.

HOLD

Current Price

$10.73

Market Cap

86.7M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
KPTI
GDO
Founded
2008
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Finance Companies
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
172.6M
86.7M
IPO Year
2013
2009

Fundamental Metrics

Financial Performance
Metric
KPTI
GDO
Price
$5.77
$10.73
Analyst Decision
Strong Buy
Analyst Count
7
0
Target Price
$14.67
N/A
AVG Volume (30 Days)
1.2M
29.0K
Earning Date
05-11-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$146,067,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$46.62
N/A
P/E Ratio
N/A
N/A
Revenue Growth
0.57
N/A
52 Week Low
$3.51
$10.29
52 Week High
$10.99
$12.15

Technical Indicators

Market Signals
Indicator
KPTI
GDO
Relative Strength Index (RSI) 35.94 39.54
Support Level $5.48 N/A
Resistance Level $6.65 $11.71
Average True Range (ATR) 0.75 0.14
MACD -0.23 0.00
Stochastic Oscillator 19.80 43.55

Price Performance

Historical Comparison
KPTI
GDO

About KPTI Karyopharm Therapeutics Inc.

Karyopharm Therapeutics Inc is a commercial-stage pharmaceutical company focused on novel cancer therapies and dedicated to the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. The company conducts research focused on intracellular communication between the nucleus and cytoplasm and has developed small-molecule compounds that inhibit exportin 1 (XPO1), a nuclear export protein. It is focused on marketing XPOVIO (selinexor).

About GDO Western Asset Global Corporate Defined Opportunity Fund Inc.

Western Asset Global Corp Defined Opp is a closed-end management investment company with a primary investment objective to provide current income. Its secondary objective is to seek capital appreciation. The Fund invests in the United States and foreign corporate fixed-income securities of varying maturities.

Share on Social Networks: